Bluebird Bio Gains 9% After Co. Begins New Phase 1 Study
February 17, 2016 at 12:52 PM EST
Shares of bluebird bio Inc (NASDAQ: BLUE) were trading higher by 9 percent on Wednesday after the company announced treatment for the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.